Stem Cell Models for Drug Discovery and Toxicology Studies
暂无分享,去创建一个
Y. Liu | Wenwei Liu | Yaguang Deng | Wen-rong Gong | W. Deng
[1] Mary Anne Wheeler,et al. Stem , 1985 .
[2] R. Poretz,et al. Lead exposure affects levels of galactolipid metabolic enzymes in the developing rat brain. , 2001, Toxicology and applied pharmacology.
[3] R. McKinnon,et al. Lead exposure delays the differentiation of oligodendroglial progenitors in vitro. , 2001, Toxicology and applied pharmacology.
[4] R. Poretz,et al. Lead alters the developmental profile of the galactolipid metabolic enzymes in cultured oligodendrocyte lineage cells. , 2001, Neurotoxicology.
[5] R. Poretz,et al. Protein kinase C activation is required for the lead-induced inhibition of proliferation and differentiation of cultured oligodendroglial progenitor cells , 2002, Brain Research.
[6] R. Poretz,et al. Oligodendroglia in developmental neurotoxicity. , 2003, Neurotoxicology.
[7] F. Jensen,et al. Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[8] F. Jensen,et al. Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] Pamela L. Follett,et al. Glutamate Receptor-Mediated Oligodendrocyte Toxicity in Periventricular Leukomalacia: A Protective Role for Topiramate , 2004, The Journal of Neuroscience.
[10] F. Jensen,et al. Oligodendrocyte excitotoxicity determined by local glutamate accumulation and mitochondrial function , 2006, Journal of neurochemistry.
[11] F. Jensen,et al. α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionate Receptor Subunit Composition and cAMP-response Element-binding Protein Regulate Oligodendrocyte Excitotoxicity* , 2006, Journal of Biological Chemistry.
[12] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[13] Shulan Tian,et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.
[14] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[15] G. Korbutt,et al. Generation of Insulin‐Producing Islet‐Like Clusters from Human Embryonic Stem Cells , 2007, Stem cells.
[16] George Q. Daley,et al. Reprogramming of human somatic cells to pluripotency with defined factors , 2008, Nature.
[17] L. Rubin. Stem Cells and Drug Discovery: The Beginning of a New Era? , 2008, Cell.
[18] Shinya Yamanaka,et al. Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors , 2008, Science.
[19] Takashi Aoi,et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.
[20] Sheng Ding,et al. A chemical approach to stem-cell biology and regenerative medicine , 2008, Nature.
[21] K. Woltjen,et al. Virus free induction of pluripotency and subsequent excision of reprogramming factors , 2009, Nature.
[22] Wei Wang,et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.
[23] R. Stewart,et al. Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.
[24] Rudolf Jaenisch,et al. Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors , 2009, Cell.
[25] Dong Wook Han,et al. Generation of induced pluripotent stem cells using recombinant proteins. , 2009, Cell stem cell.
[26] T. Cantz,et al. Induced pluripotent stem cells generated without viral integration , 2009, Hepatology.
[27] W. Deng,et al. Genome integrity: linking pluripotency and tumorgenicity. , 2009, Trends in genetics : TIG.
[28] J. R. Holt,et al. Differentiation of neurons from neural precursors generated in floating spheres from embryonic stem cells , 2009, BMC Neuroscience.
[29] Robert Lanza,et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. , 2009, Cell stem cell.
[30] W. Deng. PARylation: strengthening the connection between cancer and pluripotency. , 2009, Cell stem cell.
[31] Martin J. Aryee,et al. Epigenetic memory in induced pluripotent stem cells , 2010, Nature.
[32] X. Yang,et al. Culture conditions and enzymatic passaging of bovine ESC-like cells. , 2010, Cellular reprogramming.
[33] W. Deng. Induced pluripotent stem cells: paths to new medicines , 2010, EMBO reports.
[34] Ronald A. Li,et al. Electrophysiological properties of human induced pluripotent stem cells. , 2010, American journal of physiology. Cell physiology.
[35] Alexander Meissner,et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.
[36] W. Deng,et al. Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies. , 2010, Trends in biotechnology.
[37] W. Deng,et al. Neurobiology of injury to the developing brain , 2010, Nature Reviews Neurology.
[38] Krishanu Saha,et al. Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues , 2010, Cell.
[39] Mitsugu Sekimoto,et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. , 2011, Cell stem cell.
[40] Yunfang Wang,et al. Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue‐specific biomatrix scaffolds , 2011, Hepatology.
[41] R. Ponce. Safety assessment of immunomodulatory biologics: The promise and challenges of regulatory T-cell modulation , 2011, Journal of immunotoxicology.
[42] Andrew P. Feinberg,et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells , 2011, Nature Biotechnology.
[43] S. Przyborski,et al. Neuropharmacological properties of neurons derived from human stem cells , 2011, Neurochemistry International.
[44] Sui Huang,et al. Systems biology of stem cells: three useful perspectives to help overcome the paradigm of linear pathways , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.
[45] Ying Liu,et al. OLIG gene targeting in human pluripotent stem cells for motor neuron and oligodendrocyte differentiation , 2011, Nature Protocols.
[46] E. Heinzle,et al. In‐depth physiological characterization of primary human hepatocytes in a 3D hollow‐fiber bioreactor , 2011, Journal of tissue engineering and regenerative medicine.
[47] Mudit Gupta,et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. , 2011, Cell stem cell.
[48] M. Götz,et al. Generation of subtype-specific neurons from postnatal astroglia of the mouse cerebral cortex , 2011, Nature Protocols.
[49] Naoki Nishishita,et al. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors , 2011, Proceedings of the National Academy of Sciences.
[50] Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability , 2012, Genome Medicine.
[51] Kitai Kim,et al. Generating pluripotent stem cells: Differential epigenetic changes during cellular reprogramming , 2012, FEBS letters.
[52] Bikram Singh,et al. Thalidomide: chemistry, therapeutic potential and oxidative stress induced teratogenicity. , 2012, Current topics in medicinal chemistry.
[53] S. Cole,et al. Sequences Human Induced Pluripotent Stem Cells Free of Vector and Transgene , 2012 .
[54] G Duker,et al. Comparison of the IKr blockers moxifloxacin, dofetilide and E‐4031 in five screening models of pro‐arrhythmia reveals lack of specificity of isolated cardiomyocytes , 2012, British journal of pharmacology.
[55] W. Deng,et al. Differentiating human stem cells into neurons and glial cells for neural repair. , 2012, Frontiers in bioscience.
[56] A. Nagy,et al. Genome damage in induced pluripotent stem cells: assessing the mechanisms and their consequences. , 2013, BioEssays : news and reviews in molecular, cellular and developmental biology.
[57] H. Nakauchi,et al. Stem cell therapy: an exercise in patience and prudence , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.